Getting In Cheap On Haemonetics Corporation (NYSE:HAE) Might Be Difficult
With a price-to-earnings (or "P/E") ratio of 33.8x Haemonetics Corporation (NYSE:HAE) may be sending very bearish signals at the moment, given that almost half of all companies in the United States ha
Simply Wall StApr 17 10:09 ET
Express News | NYSE Order Imbalance 50408.0 Shares on Sell Side
Moomoo 24/7Apr 12 15:50 ET
Haemonetics Is Maintained at Outperform by Barrington Research
Haemonetics Is Maintained at Outperform by Barrington Research
Dow JonesApr 12 10:53 ET
Barrington Research Maintains Outperform on Haemonetics, Maintains $105 Price Target
Barrington Research analyst Michael Petusky maintains Haemonetics (NYSE:HAE) with a Outperform and maintains $105 price target.
BenzingaApr 12 10:43 ET
Haemonetics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/12/2024 22.12% Barrington Research $105 → $105 Maintains Outperform 02/13/2024 22.12% Barrington Resear
BenzingaApr 12 10:42 ET
Haemonetics Poised for Growth With Strong Q4 Projections and Strategic Acquisitions
TipRanksApr 12 09:15 ET
Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
BOSTON, April 10, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish fourth quarter and fiscal year 2024 financial results at 6:00 am ET on Thursda
PR NewswireApr 10 16:58 ET
Haemonetics Gets FDA Okay for TEG 6s Hemostasis Cartridge
Seeking AlphaApr 4 17:01 ET
Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative medical solutions to drive better patient...
PR NewswireApr 4 06:30 ET
Haemonetics Corporation Completes Acquisition Of Attune Medical >HAE
Haemonetics Corporation Completes Acquisition Of Attune Medical >HAE
Dow JonesApr 1 08:00 ET
Haemonetics (HAE) Crossed Above the 200-Day Moving Average: What That Means for Investors
Yahoo FinanceMar 29 09:30 ET
Does Haemonetics (NYSE:HAE) Deserve A Spot On Your Watchlist?
Yahoo FinanceMar 27 14:19 ET
Haemonetics (NYSE:HAE) Seems To Use Debt Quite Sensibly
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Simply Wall StMar 26 06:47 ET
Haemonetics Corporation (NYSE:HAE) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
With its stock down 8.4% over the past three months, it is easy to disregard Haemonetics (NYSE:HAE). But if you pay close attention, you might gather that its strong financials could mean that the s
Simply Wall StMar 8 06:08 ET
Haemonetics (HAE) Signs Agreement to Acquire Attune Medical
Yahoo FinanceMar 6 06:54 ET
Needham Remains a Hold on Haemonetics (HAE)
TipRanksMar 5 12:15 ET
Haemonetics Agrees to Acquire Esophagus-protecting Device Maker Attune Medical
MassDeviceMar 5 08:54 ET
Express News | Haemonetics Agrees To Acquire Attune Medical For An Upfront Cash Payment Of $160M Plus Additional Contingent Consideration Based On Sales Growth In The Three Years
Moomoo 24/7Mar 5 06:02 ET
Haemonetics Plans to Finance This Acquisition Through a Combination of Cash-On-Hand and a Draw Under Its Revolving Credit Facility >HAE
Haemonetics Plans to Finance This Acquisition Through a Combination of Cash-On-Hand and a Draw Under Its Revolving Credit Facility >HAE
Dow JonesMar 5 06:01 ET
Haemonetics Announces Definitive Agreement To Acquire Attune Medical >HAE
Haemonetics Announces Definitive Agreement To Acquire Attune Medical >HAE
Dow JonesMar 5 06:00 ET
No Data
No Data